在印度发现痴呆症,并制定国家特定的切断:一个机器学习和诊断分析分析
Danny Maupin1, Hongxin Gao1, Emma Nichols2,3
1School of Health Sciences Faculty of Health and Medical Sciences University of Surrey, Stag Hill University Campus Guildford UK.
Alzheimer's & dementia (Amsterdam, Netherlands)
|March 31, 2025
概括
这项研究使用机器学习为印度开发了针对特定人口的痴呆症评估截止值. 老年人认知能力下降的信息人问卷 (IQCODE) 和印度语迷你精神状态检查 (HMSE) 显示了痴呆症诊断的最佳切断线.
科学领域:
- 老年学是一门学科.
- 神经科学是一个神经科学.
- 人工智能在医学中的应用
背景情况:
- 认知评估对于痴呆症诊断至关重要,但可能会受到患者人口统计学的影响.
- 印度独特的文化和人口统计景观需要开发特定于人口的诊断切断.
- 现有的痴呆症查工具可能需要适应不同人群.
研究的目的:
- 建立可靠的,特定于印度人口的痴呆症评估截止线.
- 利用机器学习和可解释的AI来识别关键的认知评估及其最佳值.
- 为了研究这些截止点在不同的人口分组中的表现.
主要方法:
- 利用印度长度衰老研究 - 痴呆症诊断评估 (n=2528) 的数据.
- 采用了在临床医生痴呆症评级上训练的机器学习模型进行验证.
- 应用可解释的人工智能来确定特征的重要性并告知切断值.
主要成果:
- 老年人认知衰退的信息人问卷 (IQCODE) 和印度语迷你精神状态考试 (HMSE) 被确定为最具影响力的评估.
- 最佳的切割值为IQCODE的3.8和HMSE的25.
- 这些切割值在总样本中表现出色,但在某些子组中显示精度下降.
结论:
- 机器学习和可解释的人工智能可以有效地识别关键的认知评估,并为印度的痴呆症诊断建立特定人口的切断线.
- 为IQCODE和HMSE开发的切断为印度人口中痴呆症查提供了有价值的工具.
- 可能需要进一步的研究来完善难以诊断的子组的切断值.
更多相关视频
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
32.1K
09:47Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
918
相关概念视频
Dementia
76
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
76
Alzheimer's Disease: Overview
350
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
350
